ES2126151T3 - Metodo para cuantificar bpi extracelular en fluidos corporales. - Google Patents

Metodo para cuantificar bpi extracelular en fluidos corporales.

Info

Publication number
ES2126151T3
ES2126151T3 ES94928653T ES94928653T ES2126151T3 ES 2126151 T3 ES2126151 T3 ES 2126151T3 ES 94928653 T ES94928653 T ES 94928653T ES 94928653 T ES94928653 T ES 94928653T ES 2126151 T3 ES2126151 T3 ES 2126151T3
Authority
ES
Spain
Prior art keywords
body fluids
bis
quantifying
extracellular
quantifying extracellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94928653T
Other languages
English (en)
Inventor
Mark Leslie White
Stephen Fitzhugh Carroll
Jeremy Kam-Kuen Ma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Royalty Corp
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/125,677 external-priority patent/US5466580A/en
Application filed by Xoma Corp filed Critical Xoma Corp
Application granted granted Critical
Publication of ES2126151T3 publication Critical patent/ES2126151T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

EN LA PRESENTE INVENCION SE PRESENTA UN METODO PARA CUANTIFICAR LA PRESENCIA DE BPI EXTRACELULAR EN LOS FLUIDOS CORPORALES INCLUIDA LA SANGRE DE UN SUJETO QUE CONSISTE EN REALIZAR UN INMUNOENSAYO DE BPI EN LA MUESTRA DEL FLUIDO CORPORAL OBTENIDA DE DICHO SUJETO.
ES94928653T 1993-09-22 1994-09-22 Metodo para cuantificar bpi extracelular en fluidos corporales. Expired - Lifetime ES2126151T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/125,677 US5466580A (en) 1993-09-22 1993-09-22 Method for quantifying BPI in body fluids
US08/175,276 US5466581A (en) 1993-09-22 1993-12-29 Method for quantifying BPI in body fluids

Publications (1)

Publication Number Publication Date
ES2126151T3 true ES2126151T3 (es) 1999-03-16

Family

ID=26823820

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94928653T Expired - Lifetime ES2126151T3 (es) 1993-09-22 1994-09-22 Metodo para cuantificar bpi extracelular en fluidos corporales.

Country Status (12)

Country Link
US (1) US5821064A (es)
EP (1) EP0720745B1 (es)
JP (2) JPH09503296A (es)
CN (1) CN1133634A (es)
AT (1) ATE173830T1 (es)
AU (1) AU697356B2 (es)
CA (1) CA2172243C (es)
DE (1) DE69414871T2 (es)
DK (1) DK0720745T3 (es)
ES (1) ES2126151T3 (es)
NZ (1) NZ274083A (es)
WO (1) WO1995008773A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5858974A (en) * 1995-07-20 1999-01-12 Xoma Corporation Anti-fungal peptides
JP2000510845A (ja) * 1996-05-10 2000-08-22 ゾーマ コーポレイション ヒト髄膜炎菌血症のためのｂｐｉタンパク質産物の治療用途
US5741779A (en) 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
JP2000511190A (ja) * 1996-05-23 2000-08-29 ゾーマ コーポレイション 外傷に起因する出血に見舞われたヒトにおけるｂｐｉタンパク質産物の治療用途
US5888973A (en) 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
JP6651794B2 (ja) * 2015-11-05 2020-02-19 富士レビオ株式会社 心筋トロポニンｉ測定試薬及び方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245013A (en) * 1985-04-30 1993-09-14 Richard Ulevitch Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
US5198541A (en) * 1987-08-11 1993-03-30 New York University Dna encoding bactericidal/permeability-increasing proteins
US5308834A (en) * 1989-02-14 1994-05-03 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and prevention thereof using a BPI protein
US5334584A (en) * 1989-02-14 1994-08-02 Incyte Pharamaceuticals, Inc. Recombinant, non-glycosylated bpi protein and uses thereof
US5089274A (en) * 1989-02-14 1992-02-18 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
AU9127591A (en) * 1990-12-03 1992-06-25 New York University Biologically active bactericidal/permeability-increasing protein fragments
JPH07502642A (ja) * 1991-09-26 1995-03-23 インサイト　ファーマシューティカルズ，インコーポレイテッド 新規な形態のリポ糖結合性タンパク質（ｌｂｐ）
WO1993023434A2 (en) * 1992-05-19 1993-11-25 Xoma Corporation Bpi-immunoglobulin fusion proteins
ATE178652T1 (de) * 1992-05-19 1999-04-15 Xoma Corp Verbessertes verfahren zur herstellung von endotoxinbindungsproteinen
US5420019A (en) * 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
JP3946246B2 (ja) * 1993-02-02 2007-07-18 ゾーマ・コーポレイション 殺菌性／浸透性増大タンパク質（Ｂａｃｔｅｒｉｃｉｄａｌ／Ｐｅｒｍｅａｂｉｌｉｔｙ Ｉｎｃｒｅａｓｉｎｇ ｐｒｏｔｅｉｎ：ＢＰＩ）及び界面活性剤を含有する医薬組成物
US5348942A (en) * 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
EP0690721B1 (en) * 1993-03-12 1998-05-13 Xoma Corporation Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
MX9401807A (es) * 1993-03-12 1995-01-31 Xoma Corp Usos terapeuticos de productos de proteina que incrementan lapermeabilidad/bactericidas.
WO1994021280A1 (en) * 1993-03-22 1994-09-29 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis

Also Published As

Publication number Publication date
DE69414871T2 (de) 1999-06-10
JPH09503296A (ja) 1997-03-31
EP0720745B1 (en) 1998-11-25
US5821064A (en) 1998-10-13
CA2172243C (en) 2002-06-18
DE69414871D1 (de) 1999-01-07
ATE173830T1 (de) 1998-12-15
WO1995008773A1 (en) 1995-03-30
JP2003315334A (ja) 2003-11-06
HK1014207A1 (en) 1999-09-24
EP0720745A1 (en) 1996-07-10
DK0720745T3 (da) 1999-06-23
AU7801094A (en) 1995-04-10
CA2172243A1 (en) 1995-03-30
NZ274083A (en) 1998-02-26
AU697356B2 (en) 1998-10-01
CN1133634A (zh) 1996-10-16

Similar Documents

Publication Publication Date Title
ATE182216T1 (de) Verfahren zur quantifizierung von lbp in körperflüssigkeiten
DE69928809D1 (de) Differentielle diagnose von neurodegeneration
DE69111628D1 (de) Druckregler für Fluide.
FI891078A0 (fi) Peptider och antikroppar, som inhiberar plateletadhesion.
ATE328278T1 (de) Sammelapparat für einschrittigen test von mundflüssigkeiten
EP0987550A3 (en) Analytical test device and method of use
DE69014911D1 (de) Füllstandsensor für Fluide.
ES2126151T3 (es) Metodo para cuantificar bpi extracelular en fluidos corporales.
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
ATE67860T1 (de) Geraet zur fliess-injektionsanalyse.
BR9607854A (pt) Processos para a medição da taxa de degradação de uma proteína do corpo e para obtenção de informação referente à degradação de proteína em um paciente utilização de um isômero sintético de um peptídeo e de um anticorpo anticorpo capa de células análogo de peptídeo sintético e kit de análise para utilização em um processo de análise
AU1370592A (en) Immunoassay for detection of mutant p53 polypeptide in biological fluids
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
ES2078733T3 (es) Metodo para la deteccion de anticuerpos anti-arn.
ES535553A0 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
BR9913770A (pt) Processo de ensaio para determinação da cobalamina ligada a transcobalamina ii (tcii) em uma amostra de corpo, kit para uso em um ensaio diagnóstico, e, uso de holo-tc ii
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ES2136272T3 (es) Procedimientos de ensayo y dispositivos para los mismos.
DE69523492D1 (de) Immunoassay-Reagenzien, Testsätze und Verfahren
ATE130103T1 (de) Diagnostisches testsystem.
NO996464L (no) Test for karbohydratfri transferrin
CA2181815A1 (en) Method for quantifying lbp in body fluids
ATE75416T1 (de) Vorrichtung zum reinigen von gasfoermigen fluiden.
ATE302416T1 (de) Auf holo-transcobalamin ii beruhendes diagnostisches verfahren für alzheimer-krankheit
DE50209735D1 (de) Vorrichtung zur bestimmung und/oder überwachung des ph-wertes eines mediums

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 720745

Country of ref document: ES